Physicist Rosalyn S. Yalow, who shared the 1977 Nobel Prize in Physiology or Medicine for the development of a medical diagnostic test that revolutionized patient care and led to a new understanding of diabetes and a host of other diseases, died May 30 in New York City. She was 89. No cause of death was announced.
Although her work in medical diagnostics was seminal, she was perhaps equally well-known for her persistence in pursuing her goals in the face of opposition from the establishment and the opposite sex.
She was only the second woman to win the Nobel in medicine and only the sixth to win a Nobel in any science.
When Ms. Yalow and her physician colleague Solomon Berson began their research at the Bronx VA Hospital in the early 1950s, most medical diagnostics -- which involve measuring the concentrations of hormones, vitamins and other biological molecules in the blood -- were performed by strictly chemical techniques.
Such techniques were cumbersome, particularly for measuring substances present in minute concentrations. A chemical assay for adrenocorticotropic hormone or ACTH, which is produced by the pituitary gland to stimulate the production of steroid hormones, required 250 milliliters of blood, or a little over a cup -- too much to remove from a sick individual.
Ms. Yalow and Mr. Berson, who died in 1972, were in the VA hospital's new radioisotopes laboratory, which was investigating the application of such isotopes for medical purposes, such as treatment of cancer. They had been working on a way to use the atoms to monitor blood volume.
The genesis of their Nobel experiments occurred when the pair observed that insulin injected into the bloodstream of patients persisted there longer when the patients had previously been exposed to the hormone, such as for treatment of shock or what was then called adult-onset diabetes.
They reasoned that the initial exposure to extrinsic insulin led to the production of antibodies against the hormone, and that these antibodies bound to the hormone and held it in circulation longer than it would have persisted otherwise. Such a conclusion, however, was tantamount to heresy because the prevailing wisdom was that antibodies could form against only relatively large foreign objects, such as viruses and bacteria.
Peptide hormones, such as insulin, were simply too small to generate an antibody response, the conventional wisdom held. Peptides are strings of amino acids, much smaller than proteins. Undaunted, the pair pressed ahead to develop an assay for insulin and eventually developed the radioimmunoassay or RIA test.
But when they attempted to publish their findings in 1956, their paper was rejected by both the journal Science and the Journal of Clinical Investigation because it contradicted the prevailing wisdom. Ms. Yalow often showed that rejection letter in her later talks, including her Nobel acceptance speech.
In their follow-up work, the VA researchers created RIA tests for a variety of other hormones, vitamins, drugs, bacteria, viruses such as hepatitis B and other natural products. Their assay for the hepatitis virus allowed blood banks to screen for it for the first time, sharply reducing transmission via transfusions.
RIA has subsequently been displaced by related tests that use chemiluminescent or color-generating molecules as reporter molecules instead of radioisotopes.
Rosalyn Sussman was born in New York City on July 19, 1921, the daughter of parents who never finished high school. But she was imbued with a love of reading, and her older brother Alexander took her to the library every week to get a fresh load of books.
In high school, she developed an interest in chemistry, but after enrolling at Hunter College, now part of the City University of New York, her fascination switched to physics.
On her first day in graduate school at the University of Illinois she met Aaron Yalow, who became her husband in 1943. He died in 1992.
Receiving her doctorate in nuclear physics in 1945, she joined the staff back at Hunter College, where she spent three years teaching. But research called to her, and in 1947 she took a part-time position at the Bronx VA, converting to full time a year later. She spent the rest of her career there.


Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.